NYGH helps global effort in Huntington disease
North York General Hospital is part of Enroll-HD, a worldwide observational study for Huntington disease (HD) families that monitors how HD appears and changes over time.
One of the leading authorities on HD in Canada, North York General's Genetics Department is one of the top worldwide enrollers for Enroll-HD in 2015. "While it involves time and effort, it's extremely rewarding to be part of this global initiative," says Clare Gibbons, Genetics Counsellor. "What we all hope for is a cure for Huntington disease. Until then, we will do everything we can to help us get there."